Sharecafe

Chimeric Therapeutics (ASX:CHM) – Webinar Presentation

Jennifer Chow - CEO - Chimeric Therapeutics (ASX:CHM) is a clinical-stage therapy company focused on bringing the promise of cell therapy to life for more patients with cancer.

 

Jennifer Chow – CEO – Chimeric Therapeutics (ASX:CHM) is a clinical-stage therapy company focused on bringing the promise of cell therapy to life for more patients with cancer. 

Serving up fresh finance news, marker movers & expertise.
LinkedIn
Email
X

All Categories